← Back
$GLUE All transactions

Monte Rosa Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$8K

Shares

309

Price

$25

Filed

Jan 9

Insider

Name

Warmuth Markus

Title

President & CEO

CIK

0001855643

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-07

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

618,937

Footnotes

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.42 to $23.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.43 to $24.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.43 to $24.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing Info

Accession No.

0001193125-26-008902

Form Type

4

Issuer CIK

0001826457

Warmuth Markus's History

Date Ticker Type Value
2026-04-14 GLUE $141K
2026-01-07 GLUE $86K
2026-01-07 GLUE $35K
2026-01-07 GLUE $8K
2026-01-05 GLUE $154K
2026-01-02 GLUE A
2026-01-02 GLUE A $0

Other Insiders at GLUE (90d)

Insider Bought Sold Last
Warmuth Markus
President & CEO
$141K 2026-04-14
Janku Filip
Chief Medical Officer
$179K 2026-02-23
Nickson Philip
Chief Business & Legal Officer
$103K 2026-04-09
Dunn Edmund
Principal Accounting Officer
$465K 2026-03-02
Bowen Matthew
Principal Accounting Officer
2026-04-06